CPRIT’s Academic Research Program Releases Cycle 20.1 RFA

Jan 16, 2019, 17:45 PM by Melodi Moore

CPRIT announced the release of four RFAs for the Academic Research program on Monday, January 14, 2019.  The application period is March 7, 2019 through June 5, 2019. Proposals must be submitted through CPRIT’s online grant application system.

Individual Investigator Research Awards

Supports applications for innovative research projects addressing critically important questions that will significantly advance knowledge of the causes, prevention, and/or treatment of cancer. Areas of interest include laboratory research, translational studies, and/or clinical investigations.  Competitive renewal applications accepted.

Award: Up to $300,000 per year. Exceptions permitted if extremely well justified; maximum duration:  3 years.

Individual Investigator Research Awards for Cancer in Children and Adolescents

Supports applications for innovative research projects addressing questions that will advance knowledge of the causes, prevention, progression, detection, or treatment of cancer in children and adolescents. Laboratory, clinical, or population-based studies are all acceptable. CPRIT expects the outcome of the research to reduce the incidence, morbidity, or mortality from cancer in children and/or adolescents in the near or long term. Competitive renewal applications accepted.

Award: Up to $300,000 per year. Applicants that plan on conducting a clinical trial as part of the project may request up to $500,000 in total costs. Exceptions permitted if extremely well justified; maximum duration:  4 years.

Individual Investigator Research Awards for Clinical Translation

Supports applications which propose innovative clinical studies that are hypothesis driven and involve patients enrolled prospectively on a clinical trial or involve analyses of biospecimens from patients enrolled on a completed trial for which the outcomes are known. Areas of interest include clinical studies of new or repurposed drugs, hormonal therapies, immune therapies, surgery, radiation therapy, stem cell transplantation, combinations of interventions, or therapeutic devices.

Award: Up to $400,000 per year. Maximum duration:  3 years. Applicants that plan on conducting a clinical trial as part of the project may request up to $600,000 in total costs and a maximum duration of 4 years. Exceptions permitted if extremely well justified.

Individual Investigator Research Awards for Prevention and Early Detection

Supports applications for innovative research projects addressing questions that will advance knowledge of the causes, prevention, early-stage progression, and/or early detection of cancer. Research may be laboratory-, clinical-, or population- based, and may include behavioral/intervention, dissemination or health services/outcomes research to reduce cancer incidence or promote early detection. Competitive renewal applications accepted.

Award: Up to of $300,000 per year for laboratory and clinical research; Up to $500,000 per year for population-based research, including implementation research designed to accelerate the adoption and deployment of sustainable, evidence-based cancer prevention and screening interventions at multiple levels and in different clinical and community settings. Exceptions permitted if extremely well justified; maximum duration:  3 years.